INTRODUCTION
Stem cells are essential for tissue formation, maintenance, and repair by achieving a timely balance between errorfree replicative expansion and differentiation. This balance is frequently jeopardized in cancer and aging, leading to tissue pathology and functional decline Liu and Rando, 2011; Ricke and van Deursen, 2013) . To ensure accurate segregation of chromosomes during mitosis, the spindle assembly checkpoint (SAC) prevents anaphase onset until each chromosome has attached properly to mitotic spindle microtubules via its kinetochore (Foley and Kapoor, 2013; Lara-Gonzalez et al., 2012; Musacchio and Salmon, 2007) . Therefore, an active SAC will delay mitosis until all chromosomes have been properly attached and aligned.
Many molecular players participate in a spatiotemporally concerted manner to actuate the SAC. These include MAD2 (mitotic arrest deficient 2), MPS1 (monopolar spindle 1), BUB1 (budding uninhibited by benomyl 1), and BUBR1 (Foley and Kapoor, 2013; Lara-Gonzalez et al., 2012; Musacchio and Salmon, 2007; Suijkerbuijk et al., 2012) . In the presence of improperly attached kinetochores, the SAC arrests cells in mitosis by inhibiting the ability of CDC20 to activate APC/C-mediated polyubiquitination and subsequent proteasomal degradation of securin and cyclin B1 (Hwang et al., 1998; Kim et al., 1998) .
SAC disruption in different cellular contexts reveals distinct outcomes. Data from immortalized cell lines and single-cell organisms demonstrate that the consequences of SAC failure include premature onset of anaphase, mitotic slippage, chromosome missegregation, and promotion of aneuploidy (Jelluma et al., 2008; Kops et al., 2004) . In vivo studies in vertebrates and invertebrates show the consequence of SAC failure to be context dependent. During development, defective SAC activity can be tolerated early during embryogenesis but leads to an eventual loss of viability (Dobles et al., 2000; Fischer et al., 2004) . Similarly, a reduction in MAD2 and BUBR1 leads to a SAC defect that can be tolerated but accelerates tumor production (Dai et al., 2004; Michel et al., 2001) . In contrast, the SAC is essential during development and adult tissue regeneration in zebrafish (Poss et al., 2002a (Poss et al., , 2002b (Poss et al., , 2004 . Studies on the role of the SAC in stem cells are more limited. Using either germline mutants or developmentally induced Cre drivers to delete SAC genes, both hematopoietic stem cells and epidermal stem cells and their respective committed progeny display differential sensitivity to SAC disruption (Foijer et al., 2013; Ito et al., 2007) . Sensitivity to SAC dysfunction in epidermal stem cells was associated with increased aneuploidy and apoptosis (Foijer et al., 2013) .
To date, the role of the SAC exclusively in adult mammalian stem cells has not been addressed. Pax7-expressing satellite cells (SCs) possess the function of stem cells and are critical for postnatal growth and repair of adult skeletal muscle (Lepper et al., 2009; Murphy et al., 2011; Sambasivan et al., 2011; Seale et al., 2000) . Using inducible Pax7-specific SAC perturbation models, we show that the SAC is essential for normal mammalian SC function, during both early postnatal growth and adult tissue regeneration.
Deregulation of the SAC in SC progeny leads to a rapid G1 arrest and missegregation of chromosomes. p21 CIP1 is critical for the cellular arrest, and its reduction in SACdefective progenitors permits the expansion of SCs with faulty genomes. Furthermore, we show that SAC activity and the level of aneuploidy are not altered in cycling satellite cells as a function of physiological aging.
RESULTS

Muscle SCs Have a Functional Spindle Assembly Checkpoint
To investigate whether SCs have a functional spindle assembly checkpoint, we first examined expression of SAC components in quiescent and proliferating SCs. In quiescent SCs isolated by cell-surface markers (lin À , Int-a7 + , Vcam + , PI À ), Mad2 and Mps1 transcripts were barely detectable. After 3 days in culture in growth media, their levels were significantly upregulated ( Figure 1A ). To characterize the SAC component MAD2 in SCs residing within their niche, we examined single adult muscle fibers . MAD2 protein as detected by immunohistochemistry was not detectable in SCs at 0 hr but was present in activated (KI67 + ) SCs after 48 hr in culture ( Figure 1B ). To analyze MAD2 localization during progression through the cell cycle, we costained single fibers for tubulin and MAD2. In interphase, MAD2 localizes to the nuclear envelope and cytoplasm of activated SCs, but not to the nuclei of the postmitotic muscle fiber (Figures 1B and 1C ; Figure S1 ). During prometaphase, MAD2 localizes to improperly attached kinetochores and, by late metaphase, when all the chromosomes are aligned, MAD2 redistributes from the kinetochores to the cytoplasm (presumably due to 0 ,6-diamidino-2-phenylindole (DAPI) stains nuclei. n = 3 mice. (C) MAD2 (red) and tubulin (green) immunostaining at key stages of the cell cycle on single muscle fibers after 2 days in culture. DAPI stains nuclei blue. (D) Number of cells that arrest in mitosis (pH3 + cells) after exposure to mitotic poisons. Triplicate data from n = 3 mice were pooled, with 800-2,000 cells per condition. (E) Representative images of MAD2 localization in prometaphase (characterized by the tubulin staining pattern) and in the presence of mitotic poisons. The scale bars represent 10 mm (B) and 5 mm (C and E). Data are presented as mean ± SEM. *p < 0.05. n.d., not detectable. See also Figure S1 . Figure 1C ; Figure S1 ). After mitotic exit, MAD2 regains its interphase localization pattern to the nuclear envelope and cytoplasm ( Figure 1C ; Figure S1 ).
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To directly examine whether SCs have a functional SAC, we disrupted the mitotic spindle in proliferating SCs resident in their niche by treating them with either the microtubule-depolymerizing drug nocodazole or the monopolar spindle-inducing drug monastrol. Both treatments arrested SCs in mitosis as detected by phosphohistone 3 (pH3) (Figure 1D ) with unattached and/or malattached chromatids ( Figure 1E ). In both examples, MAD2 localized on the kinetochores, reflecting a functional SAC (Foley and Kapoor, 2013; Lara-Gonzalez et al., 2012; Musacchio and Salmon, 2007) (Figure 1E ). These results, for the first time, demonstrate that adult muscle SCs residing in their own niche have a robust SAC.
A Functional SAC Is Necessary for Normal Regenerative Potential of SCs
To examine the role of the SAC in SCs, we disrupted Mps1, a dual-specificity kinase with several cellular functions including regulation of microtubule dynamics, SAC regulation, and centrosomal duplication (Liu and Winey, 2012) . The binding of MPS1 to the kinetochore is essential for SAC function (Abrieu et al., 2001; Nijenhuis et al., 2013) . Therefore, to target kinetochore function while maintaining kinase activity intact, we used a conditional Mps1 mutant (Mps1D f/f) that is unable to localize to the kinetochore ( Figure S2 ) (Foijer et al., 2014; Hached et al., 2011) . This was crossed with mice harboring a tamoxifen (Tmx)-inducible Pax7-CreER tm allele and R26R-eYFP allele (hereafter Mps1D f/f). Mice containing the mutant loxP allele but lacking the Pax7-CreER tm allele were used as controls.
To determine whether disrupting Mps1 function exclusively in quiescent SCs would impact muscle regeneration, we administered Tmx prior to injury (À14 days) (Figure S3A) . Seven days after injury, the fractions of bromodeoxyuridine-positive (BrdU + ) cells (Figures S3B and S3C) and muscle fiber size ( Figures S3D-S3F) were not different between Mps1D f/f and control muscles. This raised the possibility that Mps1 is redundant for SC function in vivo. However, we found incomplete recombination of the Mps1 locus in enhanced yellow fluorescent protein-positive (eYFP + ) cells (Figures S3G and S3H) . The incongruence between full recombination at the R26R locus (indicated by eYFP) and meager recombination at the Mps1 locus possibly reflects inaccessibility of the CRE recombinase to loxP sites in the Mps1 locus in quiescent SCs. Due to the elevated expression of SAC genes in proliferating SCs in vitro, we next administered Tmx at early stages of repair (À3 to +3 days after injury) to target Mps1 in proliferating SCs (Figure 2A ). Two days after the final Tmx treatment, a high degree of recombination was evident in fluorescence-activated cell sorting (FACS)-purified myogenic cells from regenerating muscle of Mps1D f/f mice based on expression of R26R-eYFP (89% of SCs were eYFP + ) and disruption of Mps1 at the genomic level ( Figures S3G and S3H ), suggesting increased accessibility of the Mps1 locus to CRE recombinase as SCs transition from a quiescent to a proliferative state. Analysis of regenerating muscle, 7 days after injury, shows that proliferation of SC-derived progeny, based on 5-ethynyl-2 0 -deoxyuridine (EdU) incorporation, was significantly reduced in Mps1D f/f compared to control muscles (Figures 2A and 2B ). In addition, muscle fiber size was smaller, suggesting a delay in muscle repair (Figures 2D and 2E) . Thirty days after injury, muscle fiber size in Mps1D f/f mice remained smaller than both control regenerated muscle and uninjured contralateral muscle, suggesting a permanent defect in muscle repair in the absence of a functional SAC ( Figures 2D and 2E ). In addition, we observed 40% fewer sublaminar SCs of regenerated Mps1D f/f compared to control muscles (Figures 2F and 2G) . In normal muscle, SCs repopulate the niche after muscle injury, restoring the stem cell pool back to homeostatic levels (Sacco et al., 2008; . Therefore, the present results show that the SAC is essential for replenishment and homeostasis of the SC pool after injury.
SAC Is Essential for Normal SC Expansion and Differentiation during Postnatal Muscle Growth
We next examined the requirement for the SAC in SCs during postnatal myogenesis. To this end, we quantified the number of PAX7 + cells, their progeny, and muscle fiber size during postnatal maturation. Tmx was administered from postnatal day 1 (P1) to P4 followed by a 3-day chase ( Figure 3A ). At P7, we observed a high degree of recombination at both the endogenous Mps1 locus and R26R locus, as determined by eYFP expression (Figures S3G and S3H) . Immunotypic analysis at P7 revealed that Mps1D f/f muscle had 35%-60% fewer myogenic cells compared to control muscle, as assessed by the number of PAX7 + , MYOD + , and myogenin + cells ( Figures 3B and 3C ). In support, administration of EdU from P6 to P7 revealed a 50% decline in the number of proliferating (EdU + ) myogenic cells ( Figure 3D ). Furthermore, a 50% decline in muscle cross-sectional area and a commensurate decline in individual muscle fiber cross-sectional area were observed in Mps1D f/f compared to control muscle ( Figures 3E-3G ).
Together, these results demonstrate that a defective SAC limits expansion and lineage progression of the SC pool that severely limits muscle growth during postnatal maturation. 
MAD2 Depletion Phenocopies MPS1 Truncation
To assess SAC signaling during myogenesis, we conditionally disrupted Mad2 (Foijer et al., 2013), a downstream effector of Mps1 (Hewitt et al., 2010; Tighe et al., 2008) . In agreement with our Mps1 loss-of-function studies, we observed significantly smaller muscle fibers in both regenerating adult muscle ( Figure S4A ) and postnatal muscle ( Figure S4B ) in Mad2f/f compared to control mice. In conclusion, the disruption of Mps1 and Mad2 severely compromises mammalian muscle stem cell function and underscores the importance of the SAC pathway during muscle growth and repair.
SAC Defect Induces a Rapid G1 Cell-Cycle Arrest and Aneuploidy
The ability of stem cells to successfully repair tissue is critically dependent on the number and differentiation potential of their progeny. To determine the acute cellular consequence of SAC dysfunction, we disrupted Mps1 and Mad2 function in SC-derived progenitors (hereafter referred to as myoblasts) in vitro using Adeno-GFP-CRE (Ad-CRE) virus. Adeno-GFP was used as a control. We observe that Ad-CRE-treated Mps1D f/f and Mad2f/f myoblasts fail to expand and proliferate in high-serum conditions, as determined by quantification of cell numbers ( Figure 4A ; Figure S6A) . In addition, a 24-hr BrdU pulse administered 18 hr after virus treatment revealed a dramatic reduction in BrdU uptake ( Figure 4B ; Figures S5A and S6B), consistent with a reduction in S phase entry occurring within the following cell cycle.
Next, to evaluate SAC competence, Ad-CRE and Ad-GFP virus-treated Mps1D f/f myoblasts were subjected to the mitotic poison nocodazole before their entry into mitosis. In this assay, nocodazole normally elicits a mitotic arrest (legend continued on next page) response; cells that bypass the arrest are SAC defective. Compared to controls, Mps1D f/f myoblasts failed to arrest in mitosis, as evidenced by a reduction in the fraction of pH3 + cells ( Figures 4C and 4D) . Therefore, myoblasts lacking Mps1 and Mad2 function cannot mount an appropriate SAC response. Finally, cell-cycle analysis shows that Mps1D f/f myoblasts in high-serum conditions are stalled primarily in G1, with far fewer cells entering S phase ( Figure 4E ; Figure S5B) . In support, cyclin D1 transcript levels are enriched ( Figure 4F ). Thus, SAC disruption leads to mitotic slippage and a rapid arrest in G1 phase of the cell cycle. SAC dysfunction has been associated with chromosome instability and aneuploidy (Foijer et al., 2014) . To investigate whether SAC defects lead to chromosome instability in myoblasts, we assayed chromosome number using interphase fluorescence in situ hybridization (FISH) against chromosomes 15 and 19. We find an almost 2-fold increase in the number of aberrantly segregated chromosomes 24 hr following virus treatment in Mps1D f/f and Mad2f/f myoblasts compared to controls ( Figures 4G and 4H ). These data are consistent with a direct role of the SAC in prevention of aneuploidy in SC progeny.
Differentiation Is Aborted after SAC Disruption
Cell-fate decisions are controlled in G1 phase of the cell cycle (Pauklin and Vallier, 2013) . Therefore, we examined the cell fate of myoblasts shortly after SAC-dependent cell-cycle arrest. Analysis of apoptosis by Annexin V staining 48 hr after virus treatment revealed a relatively higher necrotic and apoptotic fraction in Mps1D f/f myoblasts. However, almost 90% of Mps1D f/f myoblasts are neither apoptotic nor necrotic ( Figure 5A ). In addition, senescence-associated b-galactosidase staining revealed negligible and comparable senescence between control and Mps1D f/f myoblasts ( Figures 5B and 5C ). Thus, SAC disruption in myoblasts does not substantially increase cell death or senescence.
Next, to determine whether G1-arrested Mps1D f/f and Mad2f/f myoblasts are capable of entering the myogenic differentiation program, we subjected them to serum withdrawal, an inductive environment for differentiation. In these conditions, control myoblasts lose PAX7 expression and turn on myogenin; Mps1D f/f and Mad2f/f myoblasts retain PAX7 and fail to upregulate myogenin (Figures 5D  and 5E ; Figure S6C ). In addition, Mps1D f/f myoblasts exhibit 40%-80% lower levels of MyoD and myogenin transcripts under both proliferation and differentiation conditions ( Figure 5F ). Thus, Mps1D f/f myoblasts are incapable of executing a differentiation program. To examine this defect further, we cultured control and Mps1D f/f myoblasts in low serum at high cell density to induce myoblast fusion. Control myoblasts effectively form multinucleated myotubes. In contrast, only very rare Mps1D f/f myoblasts are able to fuse and form multinucleated myotubes ( Figures  5G and 5H) . The tumor suppressor pRB is essential for effective differentiation of myoblasts (Hosoyama et al., 2011; Huh et al., 2004; Zacksenhaus et al., 1996; Gu et al., 1993; Puri et al., 2001) . Under differentiation conditions, we find that pRB levels are significantly lower in Mps1D f/f compared to control myoblasts ( Figure 5J ). Therefore, an acute loss of SAC function in committed progenitors renders them incompetent for differentiation.
Elevated p21 Levels in SAC-Deficient Myoblasts Induce a Reversible G1 Arrest Cell-cycle inhibitors balance cell replication and differentiation in normal healthy cells and induce cell-cycle arrest under conditions of DNA damage and chromosomal abnormalities (Halevy et al., 1995; LaBaer et al., 1997) . We find elevated transcript levels of the cellular stress component p21
Cip1 (hereafter called p21) in adult Ad-CRE-treated Mps1D f/f myoblasts and FACS-sorted SCs from Tmxtreated Mps1D f/f neonatal mice compared to controls ( Figures 6A-6D) . At the transcript level, other cell-cycle inhibitors such as p53, p16 INK4a , and p19 ARF were not responsive to SAC-induced arrest ( Figure S7 ). To investigate whether elevated p21 participates in the SAC-induced cell-cycle arrest and differentiation block, we reduced p21 levels in SAC-deficient cells using small hairpin RNA (shRNA) lentiviral constructs against p21 (p21KD) or scrambled shRNA (scr) ( Figure 6E ). In high-serum conditions, as expected, the majority of Mps1D f/f cells treated with scr do not proliferate, as indicated by the absence of EdU incorporation. In contrast, p21KD-Mps1D f/f cells are now able to (D and E) Representative images (D) and quantification (E) of low-density cultures from control and Mps1D f/f myoblasts switched to lowserum conditions. Cultures were stained with anti-GFP (green), anti-myogenin (white), anti-PAX7 (violet), and DAPI (blue). Experiments were counted in triplicate; n = 3 mice. (F) Relative transcript levels of myogenic-fate genes in high-serum (proliferation) and low-serum (differentiation) conditions. Triplicate data from n = 3 mice. (G and H) Images (G) and quantification (H) of control and Mps1D f/f myoblasts after switching to low-serum high-density conditions to test myogenic differentiation (anti-myosin heavy chain; green) and fusion potential. n = 3 trials for each experiment from three mice. (I and J) Immunofluorescence of pRB under differentiation conditions. n = 3 trials for each experiment from three mice. The scale bars represent 10 mm (B and I), 50 mm (D), and 20 mm (G). Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, Student's t test. See also Figure S6 . (legend continued on next page) resume the cell cycle, as determined by EdU incorporation. In addition, when switched to low-serum conditions, myogenin is upregulated, consistent with a reversal of the differentiation block ( Figures 6F and 6G ). The major cellular component regulating p21 during cellular stress is the tumor suppressor p53 (el- Deiry et al., 1993; Dimitrova et al., 2014; Harper et al., 1993; Laptenko et al., 2011; Reczek et al., 2003; Saramäki et al., 2006) . Therefore, we investigated whether reducing p53 levels by lentiviral shRNA would also unlock the cell-cycle arrest in Mps1D f/f cells. We find that EdU incorporation and differentiation in p53KD-Mps1D f/f cells was significantly increased compared to shRNA-control-Mps1Df/f cells. In control cells, proliferation and differentiation were not affected after p53KD treatment ( Figures 6H-6J ). Therefore, p21 upregulation and p53 activity are critical for cell-cycle arrest and aborted differentiation as an acute response to SAC dysfunction. Finally, we examined whether the reentry into the cell cycle after p21KD rescued the mitotic slippage. In sharp contrast to the cell-cycle rescue, reduction of p21 did not ameliorate the SAC defect (mitotic slippage) in the presence of nocodazole ( Figure 6K ; Figure S6D ) or the high levels of aneuploidy ( Figure 6L ; Figure S6E ). Therefore, restoring p21 levels allows SAC-deficient myoblasts to overcome the G1 arrest and proceed through the cell cycle; however, they proliferate with a defective SAC and elevated levels of aneuploidy.
Aged SCs Have a Robust SAC Aneuploidy confers a proliferative disadvantage on cells and increases across several tissues during aging (Baker et al., 2013; Thompson and Compton, 2008; Torres et al., 2010) . Aged SCs demonstrate impaired proliferation in vivo and in vitro (Conboy et al., 2003 (Conboy et al., , 2005 Brack et al., 2007) . We hypothesized that SAC defects underlie the age-dependent decline in SC proliferative capacity. To this end, we compared levels of the essential SAC component MAD2 in adult and aged SCs. We find that levels of MAD2 protein do not differ between adult and aged SCs in both interphase and mitosis ( Figures 7A and 7B) . Moreover, mitotic poisons elicit a similar response in activated SCs from both aged and adult mice, with cells arresting in mitosis with comparable mitotic indices ( Figure 7C ) and MAD2 localizing to the kinetochores ( Figure 7D ). Thus, SAC activity is not compromised in SCs as a function of age. In addition, the aneuploidy index, assessed by interphase FISH, in adult and aged SCs is equivalent, whether examined 2 days postisolation to inspect activated SCs or 5 days postisolation to inspect committed progenitor cells ( Figure 7E ). In conclusion, the impaired proliferative capacity exhibited by aged muscle stem cells is not due to an impaired SAC or abnormal chromosome segregation during the cell cycle.
DISCUSSION
The long-lived nature of stem cells imperils them to accumulate genomic damage or errors, which may lead to tissue degeneration or oncogenesis, depending on the cellular response to the insult. The SAC is an essential component of mitosis to ensure fidelity of chromosome segregation during replication. Using targeted approaches to target SAC function specifically in skeletal muscle stem cells, we show that the SAC is essential for muscle stem cell function both during early postnatal growth and adult tissue regeneration. Muscle stem cells lacking a functional SAC arrest in G1 phase of the cell cycle with missegregated chromosomes (aneuploidy) and are incapable of differentiation. The cell-cycle inhibitor p21 CIP1 acts as a gatekeeper to protect muscle stem cells from propagating abnormal genomes at the expense of tissue repair. Until now, only a handful of studies have investigated the role of the SAC in mammalian stem cells. When Mad2 is deleted in the murine epidermal lineage, interfollicular epidermal cells sustain growth; in contrast, hair follicular bulge stem cells fail to grow (Foijer et al., 2013) . Haploinsufficiency of Mad2 caused a reduction in the absolute numbers and cycling status of immature but not mature hematopoietic progenitor cells in both the spleen and bone marrow (Ito et al., 2007) . Thus, in vivo, depending on the cellular context, the requirement of the SAC is variable.
Satellite cells are a heterogeneous pool containing subsets with stem cell properties and others functioning as progenitors Kuang et al., 2007; Rocheteau et al., 2012) . Based on the present results, we find no evidence for differential requirements of the SAC within satellite cells as they either self-renew or progress along their lineage. However, our results do show that SAC perturbation in quiescent versus activated muscle stem cells results in different phenotypes in terms of cell proliferation and tissue regeneration. We believe this is due to the differential expression patterns of SAC genes in quiescent compared with activated stem cells. Whereas Mad2 and Mps1 are robustly expressed by activated stem cells, they are undetectable in quiescent cells. A common mechanism by which cells repress gene expression is by DNA methylation, and we surmise that the Mad2 and Mps1 gene locus in quiescent cells might be densely methylated. Indeed, it is known that CRE recombinase is unable to access loxP sites inside a methylated locus (Long and Rossi, 2009) , explaining the poor recombination efficiency of the Mps1 locus that we observe in quiescent stem cells targeted for recombination when compared to activated stem cells or progenitors. Therefore, the efficient deletion of Mps1 and Mad2 during postnatal growth and adult repair in contrast to adult uninjured muscle suggests that Mps1 and Mad2 loci undergo dynamic changes in methylation status as satellite cells transition between proliferation and quiescence. Although the mechanisms for SAC gene demethylation remain unknown, the findings implicate epigenetic regulation in the stem cell response to injury, specifically acting as a safeguard for genome integrity. Because SAC defects lead to chromosomal instability and tumor formation (Foijer et al., 2014) , it is conceivable that a quiescent stem cell that cannot upregulate SAC genes, due to epigenetic repression, may harbor some of the properties that drive a stem or progenitor cell into a tumor-initiating cell.
Genotoxic stress in various forms normally triggers cellcycle checkpoints that induce cellular arrest (Murray, 1992) . In melanocyte stem cells and hematopoietic stem cells, genotoxic stress in the form of low-dose radiation causes premature differentiation (Inomata et al., 2009; Wang et al., 2012) . Immortalized myogenic cells (C2C12) exposed to DNA-damaging agents undergo reversible inhibition of differentiation through an ABL-MYOD-regulated checkpoint (Innocenzi et al., 2011; Simonatto et al., 2011 Simonatto et al., , 2013 . Aneuploidy is a genotoxic stress and is detrimental to cell survival; cancer cells that tolerate aneuploidy can propagate themselves (Foijer et al., 2014; Thompson and Compton, 2010) . In the present study, we demonstrate that activated SCs subjected to genotoxic stress by aneuploidy do not undergo acute cell death, senescence, or terminal differentiation. Instead, they reside in a stable but reversible G1-arrested state. Therefore, distinct genotoxic stressors may create relatively diverse phenotypes in damaged tissues. Although studied extensively for its effect on cell proliferation, little is known about the impact of aneuploidy on differentiation. Our data suggest aneuploidy to be detrimental to differentiation to limit tissue contribution of faulty genomes. Although diminished, integration of SCs lacking a functional SAC (based on R26R-eYFP expression and genomic recombination at Mps1 and Mad2 loci) into growing and injured regenerating tissue suggests that some SAC-deficient activated SCs are indeed capable of tissue contribution. It will be important to assess the long-term consequences of aneuploidy on the function of a stable postmitotic tissue, such as skeletal muscle. p21 is a cell-cycle inhibitor that can initiate terminal differentiation and cause cell-cycle arrest in response to genotoxic stress, with forced p21 overexpression inducing differentiation even in high serum (Halevy et al., 1995; Skapek et al., 1995) . In the present work, we have uncoupled a p21-mediated cell-cycle arrest in response to aneuploidy-induced genotoxic stress and for differentiation. We propose that p21 induction reflects either competence for differentiation or a protective response to cellular stress rather than predicting cell fate.
The differentiation block of myogenic cells undergoing genotoxic stress should be kept in mind while designing therapies for rhabdomyosarcoma (RMS), a soft-tissue sarcoma whose cell of origin is a myogenic precursor (Rubin et al., 2011) . RMS is notorious for its inability to terminally differentiate, and this is often correlated with poor prognosis (Saab et al., 2011) . We speculate that treating RMS with genome-damaging drugs could potentially exacerbate its inability to differentiate. This information might be valuable in designing myodifferentiation therapies for RMS, especially if the RMS is being treated with DNAdamaging agents such as cisplatin or if the RMS in question might be aneuploid, such as embryonic RMS from mosaic variegated aneuploidy patients, who have mutations in the SAC gene Bub1B.
Genome integrity is compromised across several different tissues during aging via structural (DNA damage, telomere shortening) and numerical (aneuploidy) aberrations of DNA (Behrens et al., 2014; Blanpain et al., 2011; Mandal et al., 2011) . In fact, aneuploidization during aging has been observed across many somatic tissues (Baker et al., 2013) ; moreover, overexpression of the SAC gene BUBR1 can ameliorate many pathologic phenotypes in an accelerated aging model. Despite the dramatic decline in stem cell function during aging Cosgrove et al., 2014; Bernet et al., 2014; Sousa-Victor et al., 2014) , satellite cells do not undergo age-induced aneuploidization in noninjured muscle (Baker et al., 2013) . Importantly, adult SCs undergo limited divisions throughout life, with estimates ranging from four to eight divisions based on a TetO-H2B-GFP reporter , which suggests that aneuploidization does not increase as a function of chronological aging in stem cells. Thus, the protective effects of BUBR1 overexpression against aging might be independent of its role in the SAC. We now show that when aged SCs are induced to proliferate, they are able to mount an equally robust SAC and have comparable levels of aneuploidy relative to proliferating adult SCs. Despite the robust SAC activity in aged SCs, we cannot rule out malfunction in other mitotic processes as an underlying cause for their limited function.
In multicellular organisms, tissue-specific stem cell proliferation is steered toward self-renewal or differentiation for tissue development or regeneration. Thus, fidelity of chromosome segregation is essential during stem cell proliferation so that organs are not built on cells with compromised genomic integrity. Although quiescent SCs in mammals do not express SAC proteins, they are expressed and used diligently by cycling SCs. To ensure genomic integrity during tissue turnover, adult muscle stem cells utilize a p53-and p21-mediated pathway to block the proliferation of cells with a dysfunctional SAC. Thus, the SAC, along with p53 and p21, helps stem cells to maintain a balance between meeting the demands of building the tissue and preserving genomic integrity favoring genome preservation over tissue homeostasis.
EXPERIMENTAL PROCEDURES
Animals
Conditional alleles for Mad2 and Mps1 were generated and provided by Peter Sorger (Foijer et al., 2014; Hached et al., 2011) . They were crossed with Pax7-CreER tm mice (Nishijo et al., 2009) on a C57BL/6 background to carry out tissue-specific deletions. C57BL/6 mice were procured from Charles River Laboratories or from the National Institute on Aging. Mice were used at 4-6 months of age (adult) or 22-24 months (aged). Animals were housed and handled in accordance with the guidelines of the Massachusetts General Hospital Subcommittee on Research Animal Care.
Muscle Injury and Proliferation Assessment
Muscle injury and analysis of regenerating muscle fibers were performed as previously described . EdU (Carbosynth) in PBS (2.5 mg/ml) was intraperitoneally injected into adults (two doses of 70 ml/day) and subcutaneously injected into pups (two doses of 20 ml/day). EdU detection was carried out according to the manufacturer's instructions (Click-iT EdU detection; Invitrogen). One dose of 150 ml of 1.5 mg/ml BrdU (Sigma) was intraperitoneally injected into adults along with 2.5 mg/ml BrdU in 5% sucrose water for drinking. 
